The expression of the following oncogene is associated with a high incidence of medullary carcinoma of the thyroid
**Core Concept**
The expression of specific oncogenes can contribute to the development and progression of various cancers, including medullary carcinoma of the thyroid. This cancer type originates from the parafollicular cells (also known as C cells) of the thyroid gland, which produce calcitonin.
**Why the Correct Answer is Right**
Medullary carcinoma of the thyroid is often associated with the expression of the RET proto-oncogene. RET is a receptor tyrosine kinase that plays a crucial role in the signaling pathways of the parafollicular cells. Mutations in the RET gene can lead to the constitutive activation of the receptor, promoting cell proliferation and tumor formation. The RET proto-oncogene is implicated in approximately 25% of medullary thyroid carcinoma cases, often as a result of germline mutations that are inherited in an autosomal dominant pattern.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is not relevant to medullary carcinoma of the thyroid. While other oncogenes, such as BRAF, are associated with thyroid cancer, they are primarily linked to papillary thyroid carcinoma.
**Option B:** This option is incorrect because the expression of this oncogene is not specifically associated with medullary carcinoma of the thyroid. Other types of cancer, such as lung or breast cancer, may be linked to this oncogene.
**Option C:** This option is not correct because while this oncogene is involved in various cancers, it is not specifically associated with medullary carcinoma of the thyroid.
**Clinical Pearl / High-Yield Fact**
It is essential to recognize the genetic basis of medullary thyroid carcinoma, as familial cases can be identified through genetic testing. Patients with a family history of medullary thyroid carcinoma or other associated conditions, such as pheochromocytoma or Hirschsprung's disease, should undergo screening for RET mutations.
**Correct Answer:** C.